Mid-Year Report — ASTRAZENECA PHARMACEUTICALS LP for ASTRAZENECA PHARMACEUTICALS LP (2007)

Firm

ASTRAZENECA PHARMACEUTICALS LP

Client

ASTRAZENECA PHARMACEUTICALS LP

Income

—

Expenses

$2,380,000

What was lobbied

6 issue areas, each in the filer's own words, with who lobbied on it and where.

Copyright/Patent/Trademark CPT

S. 316 & H.R. 1432 - Preserve Access to Affordable Generics Act H.R. 1902 - Protecting Access to Generic Drugs Act of 2007 H.R. 1908-Patent Reform Act of 2007 H.R. 1038-Access to Life-Saving Medicine Act - Follow-on Biologics H.R. 1956-Patient Protection and Innovative Biologic Medicines Act of 2007 S.1145-Patent Reform Act of 2007

Lobbyist	Covered position, as disclosed
RICHARD BUCKLEY	N/A
KAREN DAY	N/A
ANDRES IZQUIERDO	N/A
JACQUELINE POMFRET KIRBY	—
DEANA MCRAE	N/A
AMANDA GRASHOF MOTT	N/A
RICHARD WAYNE OLSON	N/A
WAYNE PALMER	N/A
BRADLEY ALLEN ROSSIN	N/A
JENNIFER STEWART	—

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 1038 (110th), H.R. 1956 (110th), H.R. 1432 (110th), S. 1145 (110th), H.R. 1908 (110th), S. 316 (110th), H.R. 1902 (110th)

Medicare/Medicaid MMM

S.3 - Medicare Prescription Drug Price Negotiation Act of 2007 H.R. 4 - Medicare Prescription Drug Price Negotiation Act of 2007 Medicaid Rebate Rate

Lobbyist	Covered position, as disclosed
RICHARD BUCKLEY	N/A
KAREN DAY	N/A
ANDRES IZQUIERDO	N/A
JACQUELINE POMFRET KIRBY	—
DEANA MCRAE	N/A
AMANDA GRASHOF MOTT	N/A
RICHARD WAYNE OLSON	N/A
WAYNE PALMER	N/A
BRADLEY ALLEN ROSSIN	N/A
JENNIFER STEWART	—

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 4 (110th), S. 3 (110th)

Health Issues HCR

H.R. 1424 The Paul Wellstone Mental Health and Addiction Equity Act of 2007 S. 1893-Children's Health Insurance Program Reauthorization Act H.R. 3162-Children's Health Insurance Program Reauthorization Act S.558-The Mental Health Parity Act of 2007 S. 1376 - 340B Program Improvement and Integrity Act of 2007

Lobbyist	Covered position, as disclosed
RICHARD BUCKLEY	N/A
KAREN DAY	N/A
ANDRES IZQUIERDO	N/A
JACQUELINE POMFRET KIRBY	—
DEANA MCRAE	N/A
AMANDA GRASHOF MOTT	N/A
RICHARD WAYNE OLSON	N/A
WAYNE PALMER	N/A
BRADLEY ALLEN ROSSIN	N/A
JENNIFER STEWART	—

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 1893 (110th), H.R. 3162 (110th), S. 1376 (110th), S. 558 (110th), H.R. 1424 (110th)

Consumer Issues/Safety/Products CSP

Drug Importation Issues S.A. 1010 - Safety and Cost Savings Certification re: Importation of Pharmaceuticals S. 242 & H.R.380 - Pharmaceutical Market Access and Drug Safety Act of 2007 Safe Drug Compounding Act of 2007 (draft legislation - no bill number)

Lobbyist	Covered position, as disclosed
RICHARD BUCKLEY	N/A
KAREN DAY	N/A
ANDRES IZQUIERDO	N/A
JACQUELINE POMFRET KIRBY	—
DEANA MCRAE	N/A
AMANDA GRASHOF MOTT	N/A
RICHARD WAYNE OLSON	N/A
WAYNE PALMER	N/A
BRADLEY ALLEN ROSSIN	N/A
JENNIFER STEWART	—

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 242 (110th), H.R. 380 (110th)

Pharmacy PHA

S.1082-Food and Drug Administration Revitalization Act of 2007 H.R. 2900 Food and Drug Administration Amendments Act of 2007 Illegal Pharmaceutical Manufacturing S.1859 Agriculture Appropriations - Title VI: Food and Drug Administration

Lobbyist	Covered position, as disclosed
RICHARD BUCKLEY	N/A
KAREN DAY	N/A
ANDRES IZQUIERDO	N/A
JACQUELINE POMFRET KIRBY	—
DEANA MCRAE	N/A
AMANDA GRASHOF MOTT	N/A
RICHARD WAYNE OLSON	N/A
WAYNE PALMER	N/A
BRADLEY ALLEN ROSSIN	N/A
JENNIFER STEWART	—

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 2900 (110th), S. 1082 (110th), S. 1859 (110th)

Medical/Disease Research/Clinical Labs MED

S.5 & H.R. 3 - Stem Cell Research Enhancement Act of 2007

Lobbyist	Covered position, as disclosed
RICHARD BUCKLEY	N/A
KAREN DAY	N/A
ANDRES IZQUIERDO	N/A
JACQUELINE POMFRET KIRBY	—
DEANA MCRAE	N/A
AMANDA GRASHOF MOTT	N/A
RICHARD WAYNE OLSON	N/A
WAYNE PALMER	N/A
BRADLEY ALLEN ROSSIN	N/A
JENNIFER STEWART	—

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 3 (110th), S. 5 (110th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.